SGR-2921

· Schrödinger, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SGR-2921, covering 2025-09-22 to 2025-09-22. Get the full timeline:

Most recent: Clinical Trial Update: Study of SGR-2921 in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome [Phase 1]